U.S. Stock SEC Cash-Flow Directory / Healthcare

ATRCAvoid

AtriCure, Inc. · Surgical & Medical Instruments & Apparatus

TFE Standardized Verdict
Avoid
Impersonal model classification
Official SEC Free Cash Flow
-$7.8M
SEC Form 10-Q (filed 2026-05-10)
Trend Episodes
Breaking Down
Multi-episode price & volume path
vs. S&P 500 Benchmark
Leading S&P 500
Relative leadership check
Counterpoint — What Independent Investors Should Watch Out For

Core Operations Burning Cash in Latest SEC Filing

Cash runway question: operations used $4.0M of cash before $3.9M in capital spending — ask how long existing liquidity (4.33x current ratio) lasts without issuing new shares or debt.

3 Plain-English Questions to Ask Before Buying or Holding ATRC:
  • Why did ATRC's capital spending push official SEC Free Cash Flow negative (-$7.8M), and when will cash generation turn positive again?
  • What downside exit rule protects my portfolio if ATRC's current breakdown continues?
  • Are there stronger Healthcare companies generating positive SEC Free Cash Flow with healthier trend support right now?

Official U.S. SEC EDGAR Filing Snapshot (ATRC)

Period Ended 2026-03-31 · Filed 2026-05-10
Revenues
$141.2M
Gross Margin
77.4%
Operating Cash Flow
-$4.0M
Capital Spending (CapEx)
$3.9M
Free Cash Flow
-$7.8M
Current Ratio
4.33x
Long-Term Debt
$61.0M
Subscriber Research Workbench • Founding 1000 Launch Offer

See All 36 Healthcare Stocks Rated Accumulate Right Now

Every TFE Accumulate stock requires verified positive SEC Free Cash Flow, constructive multi-episode trend durability, and S&P 500 relative strength. Unlock the full 254-stock Accumulate roster, full 2,400+ stock Screener, and personal Watchlist.

Claim Founding 1000 Access — $25 / Full Year →One-time 12-month pass (capped at 1,000 members) · Or $9.99/mo
Check Other Popular U.S. Stocks:
AMZN SEC Checkup →NVDA SEC Checkup →AAPL SEC Checkup →GOOGL SEC Checkup →MSFT SEC Checkup →COST SEC Checkup →PLTR SEC Checkup →KO SEC Checkup →Browse All 2,728 Stocks →

Research Disclosure: Standardized impersonal model publication for research use only — not personalized investment advice and not a brokerage site. Verify all filings and live quotes independently before making investment decisions.